About transmitid

This author has not yet filled in any details.
So far transmitid has created 46 blog entries.

Buprenorphine Prescribing: To Expand or Not to Expand

View Article

May 18th, 2016|Article, Uncategorized|0 Comments

A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction

View Article

January 27th, 2016|Article, Uncategorized|0 Comments

Addiction: Learning vs. The Disease Model

View Article

January 7th, 2016|Article, Uncategorized|0 Comments

The Case Against Residential Rehab

CATR, July / August 2015, Vol 3, Issue 5, Residential Treatment Programs Decoded

Mark Willenbring, MD
Founder and CEO, Alltyr Clinic, St. Paul, MN, Former Director, Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD

Dr. Willenbring has disclosed that he has no relevant financial or other interests in any commercial companies […]

September 24th, 2015|Article, Uncategorized|0 Comments

New Info On Trends in Substance Use in the U.S.

View the Article

September 17th, 2015|Article, Uncategorized|0 Comments

The Irrationality of Alcoholics Anonymous

Click to read the article

May 26th, 2015|Article, Uncategorized|0 Comments

What I’ve Finally Concluded About 12-Step Programs After 25 Years Writing About Drugs and Addiction

Alcoholics Anonymous and the rest remain the biggest and most polarizing force in the addiction community. I quit heroin and cocaine using the steps and have covered addiction as a journalist—and I’d argue that the picture is decidedly mixed.
Anyone who deals with addiction in America has to reckon with Alcoholics […]

April 20th, 2015|Article, Uncategorized|0 Comments

Uses of diverted methadone and buprenorphine by opioid- addicted individuals in Baltimore, Maryland

Download PDF to view article

April 20th, 2015|Article, Uncategorized|0 Comments

The Science of Addiction

Download to view article

April 20th, 2015|Article, Uncategorized|0 Comments

Response to Ohio State Medical Board

To The Ohio State Medical Board,

It has come to our attention that the Board is proposing some very significant changes on the requirements for Buprenorphine prescribing. The intent of this letter is for us to review some of the concerns we have and how we believe they will harm patient care, reduce access to treatment and lead to […]

April 20th, 2015|Article, Uncategorized|0 Comments